320
+1.27%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Yuki Gosei Kogyo Co
Its shares trade on Tokyo Stock Exchange under the ticker 4531.T. It has been listed since 2 October 1962. In the fiscal year to 31 March 2026, it reported revenue of ¥15.45bn and net income of ¥313.0m. At that date it held total assets of ¥25.73bn and shareholders' equity of ¥13.49bn.
Yuki Gosei Kogyo Co. Ltd. engages in the manufacture and sale of medical products. The company is headquartered in Chuo-Ku, Tokyo-To. The amino acids business is involved in the manufacture and sale of amino acids and vitamin ingredients. The chemical products business in involved in the manufacture and sale of the tire cord adhesive raw materials, agricultural chemical intermediates, silicon compounds and other products. The pharmaceuticals business is involved in the manufacture and sale of the pharmaceutical raw materials and intermediates. The commission of manufacture operation business is involved in the contract for manufacture operations through subsidiaries. The firm is also involved in the manufacture and sale of foods, food additives, feed additives, fragrances, and cosmetics, as well as the sale of the related raw materials and products.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 2 Oct 1962
- Employees
- 295
- Website
- yuki-gosei.co.jp ↗
Leadership
Pay as last reported
- Mr. Seiichiro MatsumotoExecutive President, Chief Executive Officer, Representative Director, since 2017
- Mr. Masahiro KusanoManaging Executive Officer, Director, since 2020
- Mr. Masao MatsukawaSenior Executive Officer, Senior Director of Sales, Director of 1st Sales
- Mr. Tatsuya KomatsubaraSenior Executive Officer, Director, since 2018
- Mr. Hiromi IshikawaExecutive Officer, Director of General Affairs and Human Resources
- Mr. Makoto KitoExecutive Officer, Director of Production Engineering, Joban Plant Manager
- Mr. Hiroshi NakamuraExecutive Officer, Director of Quality Assurance
- Mr. Naotake SutoDirector
- Mr. Norito OhoriIndependent Director
- Mr. Keisuke YamadaIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- The company operates in the materials sector with a chemical industry focus.
- It employs 295 full-time staff members across its operations.
- The firm manufactures medical products and various chemical intermediates.
Weaknesses
- The business is concentrated in a single city in Japan.
- It relies on a relatively small workforce for its diverse product lines.
- The company has limited public information available beyond basic facts.
Opportunities
- The firm can expand its amino acids and vitamin ingredient sales.
- Growth is possible in pharmaceutical raw materials and intermediates.
- The company may increase contract manufacturing operations through subsidiaries.
Threats
- Market fluctuations could impact the sale of tire cord adhesives.
- Competition exists in the agricultural chemical intermediates sector.
- Regulatory changes may affect the manufacture of food additives.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.